Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (1-10 of 492) with videos related to

Pageof 50
Sort By:
Nature Clinical Practice. Rheumatology|April 3, 2008
Is sitaxsentan a good therapeutic option for pulmonary arterial hypertension associated with connective tissue disease?Yannick Allanore
Joint Bone Spine|February 28, 2007
Cardiovascular mortality in patients with inflammatory rheumatic disordersYannick Allanore
Joint Bone Spine|December 8, 2019
Stem cells: Hope for systemic sclerosis patients?Yannick Allanore
Joint Bone Spine|March 14, 2012
Phosphodiesterase 5 inhibitors in vascular systemic disordersYannick Allanore
Medecine Sciences : M/S|March 4, 2016
[Pathophysiology of systemic sclerosis]Yannick Allanore
Clinical and Experimental Rheumatology|April 19, 2014
Targeted immunotherapies in systemic sclerosisJérôme Avouac, Yannick Allanore
Chest|July 15, 2006
Abnormal right ventricular diastolic function may not be the only early marker of myocardial involvement in systemic sclerosisChristophe Meune, Yannick Allanore
Presse Medicale (Paris, France : 1983)|December 13, 2006
[Heart involvement in systemic sclerosis]Yannick Allanore, André Kahan
Arthritis & Rheumatology (Hoboken, N.J.)|January 27, 2025
Systemic Sclerosis: A Multisystem Disease; Time to Think Beyond SclerodermaYannick Allanore, Shervin Assassi
Bulletin De L'Academie Nationale De Medecine|November 2, 2011
[Genetics and pathophysiology of systemic sclerosis]Yannick Allanore, Catherine Boileau
Pageof 50

Showing results (1-10 of 492) with videos related to

Sort By:
Pageof 50
Nature Clinical Practice. Rheumatology|April 3, 2008
Is sitaxsentan a good therapeutic option for pulmonary arterial hypertension associated with connective tissue disease?Yannick Allanore
Joint Bone Spine|February 28, 2007
Cardiovascular mortality in patients with inflammatory rheumatic disordersYannick Allanore
Joint Bone Spine|December 8, 2019
Stem cells: Hope for systemic sclerosis patients?Yannick Allanore
Joint Bone Spine|March 14, 2012
Phosphodiesterase 5 inhibitors in vascular systemic disordersYannick Allanore
Medecine Sciences : M/S|March 4, 2016
[Pathophysiology of systemic sclerosis]Yannick Allanore
Clinical and Experimental Rheumatology|April 19, 2014
Targeted immunotherapies in systemic sclerosisJérôme Avouac, Yannick Allanore
Chest|July 15, 2006
Abnormal right ventricular diastolic function may not be the only early marker of myocardial involvement in systemic sclerosisChristophe Meune, Yannick Allanore
Presse Medicale (Paris, France : 1983)|December 13, 2006
[Heart involvement in systemic sclerosis]Yannick Allanore, André Kahan
Arthritis & Rheumatology (Hoboken, N.J.)|January 27, 2025
Systemic Sclerosis: A Multisystem Disease; Time to Think Beyond SclerodermaYannick Allanore, Shervin Assassi
Bulletin De L'Academie Nationale De Medecine|November 2, 2011
[Genetics and pathophysiology of systemic sclerosis]Yannick Allanore, Catherine Boileau
Pageof 50